Nov 08, 2017 21:02 pm UTC| Business
SAN DIEGO, Nov. 08, 2017 -- Kratos Defense Security Solutions, Inc. (“Kratos”) (Nasdaq:KTOS), announced today that it has priced a private offering of $300 million aggregate principal amount of 6.50% Senior Secured...
Pegasystems Announces Third Quarter 2017 Financial Results
Nov 08, 2017 21:02 pm UTC| Business
Term License and Cloud ACV grew by 23% year over yearTerm License, Cloud, and Maintenance ACV grew by 17% year over year to $449 millionLicense and Cloud Backlog increases 29% year over year CAMBRIDGE, Mass., Nov. 08,...
FibroGen Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:02 pm UTC| Business
Roxadustat NDA Filing Accepted for CFDA Review; Positive Pamrevlumab Phase 2 IPF Results ReportedConference Call and Webcast to be Held Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time SAN FRANCISCO, Nov. 08,...
Stericycle, Inc. Reports Third-Quarter 2017 Results
Nov 08, 2017 21:02 pm UTC| Business
LAKE FOREST, Ill., Nov. 08, 2017 -- Stericycle, Inc. (NASDAQ:SRCL) today reported results for the third quarter ended September 30, 2017. THIRD-QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: Revenues of $882.8...
The Children’s Place to Webcast Review of Third Quarter 2017 Financial Results
Nov 08, 2017 21:02 pm UTC| Business
SECAUCUS, N.J., Nov. 08, 2017 -- The Children’s Place, Inc. (Nasdaq:PLCE) today announced that in conjunction with the release of its Third Quarter 2017 financial results, you are invited to listen to the Company’s...
Nov 08, 2017 21:02 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 08, 2017 -- TPI Composites, Inc. (Nasdaq:TPIC), the only independent manufacturer of composite wind blades with a global footprint, today reported financial results for the third quarter ended...
Adverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 08, 2017 21:02 pm UTC| Business
MENLO PARK, Calif., Nov. 08, 2017 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a leading gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today reported financial results for...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update